Finanzwire Finanzwire
Basculer en Français
10336 Companies
214540 Keywords
144364 Articles
113636 Press releases
Headlines Articles Press releases Belhaven Biopharma Remove
  1. Home
  2. Companies
  3. Belhaven Biopharma
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 07/09/2024 at 17:05, 1 year 9 months ago

    Belhaven Biopharma Study Shows Promising Results for Nasal Epinephrine Delivery

    Belhaven Biopharma Nasdepi Anaphylaxis Treatment Medical Research Nasal Epinephrine
  • PRESS RELEASE

    published on 07/09/2024 at 17:00, 1 year 9 months ago

    New Canine Study From Belhaven Biopharma Supports Dry Powder Nasal Epinephrine Delivery Solution

    Belhaven Biopharma presents promising results of Nasdepi Canine Study at Respiratory Drug Delivery 2024, indicating faster & effective treatment for anaphylaxis. Intranasal dry powder epinephrine offers breakthrough prospects in emergency care for severe allergies
    Belhaven Biopharma Anaphylaxis Treatment Nasdepi Canine Study Dry Powder Nasal Solution Respiratory Drug Delivery 2024
    Logo of Belhaven Biopharma
  • PRESS RELEASE

    published on 02/08/2024 at 18:30, 2 years 2 months ago

    Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product

    Belhaven Biopharma shares positive results from Phase 1 clinical trial of Nasdepi, a nasal dry powder epinephrine device for treating anaphylaxis. Successful investor round and Series A financing on the horizon
    Phase 1 Clinical Trial Series A Financing Belhaven Biopharma Nasdepi Anaphylaxis Treatment
    Logo of Belhaven Biopharma
  • PRESS RELEASE

    published on 11/28/2023 at 19:30, 2 years 5 months ago

    Belhaven Biopharma Achieves Significant Milestones in Advancing Nasdepi - a Revolutionary Nasal Dry Powder Epinephrine Product

    Logo of Belhaven Biopharma
Accesswire
  • Published on 05/01/2026 at 22:30, 21 minutes ago

    Nextech3D.ai Appoints New Independent Auditor

  • Published on 05/01/2026 at 22:30, 21 minutes ago

    Integrated Rewards Achieves SOC 2 Compliance to Support Enterprise-Scale Growth Across Canada's Card-Linked Rewards Network as EQ Closes Convertible Debt Financing

  • Published on 05/01/2026 at 22:30, 21 minutes ago

    Apex Critical Metals Announces Extension of Marketing Agreement with Rumble Strip Media Inc.

  • Published on 05/01/2026 at 18:00, 4 hours 51 minutes ago

    Star Copper to Present at the Emerging Growth Conference on May 7, 2026

  • Published on 05/01/2026 at 15:35, 7 hours 16 minutes ago

    LNG Energy Group Announces Partial Revocation of Cease Trade Order and Proposed Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 05/01/2026 at 19:23, 3 hours 28 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 05/01/2026 at 18:40, 4 hours 11 minutes ago

    Holding(s) in Company

  • Published on 05/01/2026 at 17:47, 5 hours 4 minutes ago

    Key Figures 30.04.2026

  • Published on 05/01/2026 at 17:45, 5 hours 6 minutes ago

    Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)

  • Published on 05/01/2026 at 17:21, 5 hours 29 minutes ago

    Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares

View all EQS
Les Echos
  • Published on 04/30/2026 at 20:00, 1 day 2 hours ago

    AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue

  • Published on 04/30/2026 at 19:16, 1 day 3 hours ago

    AXA announces the results of its Shareholders' Meeting

  • Published on 04/30/2026 at 19:00, 1 day 3 hours ago

    Capital increase through exercise of subscription rights

  • Published on 04/30/2026 at 18:10, 1 day 4 hours ago

    Minutes of the Combined General Meeting held on April 30, 2026

  • Published on 04/30/2026 at 18:00, 1 day 4 hours ago

    TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy